Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology


Gumusay O., Coskun U., Akman T., Ekinci A. S., Kocar M., Erceleb O. B., ...Daha Fazla

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, cilt.140, sa.1, ss.151-157, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 140 Sayı: 1
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1007/s00432-013-1553-7
  • Dergi Adı: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.151-157
  • Anahtar Kelimeler: Melanoma, Brain metastases, Predictive factors, CENTRAL-NERVOUS-SYSTEM, CEREBRAL METASTASES, CUTANEOUS MELANOMA, PROGNOSTIC-FACTORS, THERAPY, SURVIVAL, LYMPHADENECTOMY, FEATURES, TRIAL, STAGE
  • Gazi Üniversitesi Adresli: Evet

Özet

The development of brain metastases (BMs) was associated with poor prognosis in melanoma patients. Patients with BMs have a median survival of < 6 months. Melanoma is the third most common tumor to metastasize to the brain with a reported incidence of 10-40 %. Our aim was to identify factors predicting development of BMs and survival.